N. E. B. Aykanat Et Al. , "Silymarin suppresses HepG2 hepatocarcinoma cell progression through downregulation of Slit-2/Robo-1 pathway," PHARMACOLOGICAL REPORTS , vol.72, no.1, pp.199-207, 2020
Aykanat, N. E. B. Et Al. 2020. Silymarin suppresses HepG2 hepatocarcinoma cell progression through downregulation of Slit-2/Robo-1 pathway. PHARMACOLOGICAL REPORTS , vol.72, no.1 , 199-207.
Aykanat, N. E. B., KAÇAR, S., KARAKAYA, Ş., & ŞAHİNTÜRK, V., (2020). Silymarin suppresses HepG2 hepatocarcinoma cell progression through downregulation of Slit-2/Robo-1 pathway. PHARMACOLOGICAL REPORTS , vol.72, no.1, 199-207.
Aykanat, Nuriye Et Al. "Silymarin suppresses HepG2 hepatocarcinoma cell progression through downregulation of Slit-2/Robo-1 pathway," PHARMACOLOGICAL REPORTS , vol.72, no.1, 199-207, 2020
Aykanat, Nuriye E. Et Al. "Silymarin suppresses HepG2 hepatocarcinoma cell progression through downregulation of Slit-2/Robo-1 pathway." PHARMACOLOGICAL REPORTS , vol.72, no.1, pp.199-207, 2020
Aykanat, N. E. B. Et Al. (2020) . "Silymarin suppresses HepG2 hepatocarcinoma cell progression through downregulation of Slit-2/Robo-1 pathway." PHARMACOLOGICAL REPORTS , vol.72, no.1, pp.199-207.
@article{article, author={Nuriye Ezgi Bektur Aykanat Et Al. }, title={Silymarin suppresses HepG2 hepatocarcinoma cell progression through downregulation of Slit-2/Robo-1 pathway}, journal={PHARMACOLOGICAL REPORTS}, year=2020, pages={199-207} }